Pharmaceuticals
Ranbaxy TPP Generic Nexium, Diovan, and Valcyte Settlement
Sun Pharmaceutical Industries, Ltd. and Ranbaxy, Inc. are settling combined class actions alleging generic drug manufacturer Ranbaxy made misrepresentations about both the conditions in its plants and the results of analyses on the integrity of data at the plants. This allowed it to obtain “tentative approval” from the Food and Drug Administration (FDA) and a Read more
Avanir Encouraged Nuedexta Use for Off-Label Purposes Class Action
When drugs are approved by the Food and Drug Administration (FDA), they are approved for specific uses, to treat specific diseases or problems. The complaint for this class action brings suit against Avanir Pharmaceuticals, Inc., which it claims attempted to market a drug called Nuedexta for other than its original uses, including, it claims, by Read more
Pfizer Chantix Contaminated with NDMA Class Action
Pfizer makes the drug Chantix to help people stop smoking. The complaint refers to Chantix as a VCD, or varenicline-containing drug. But the complaint for this class action alleges that the company has been putting out adulterated or misbranded Chantix that has been contaminated with “a probable human carcinogen known as n-nitroso-varenicline.” The complaint alleges Read more
Geron Conceals Study Results, Sells Inflated Stock Class Action
Geron Corporation, a biopharmaceutical company, had just one drug in its pipeline, imetelstat. The complaint for this class action alleges that a Phase 2 clinical trial for the drug produced disappointing results. Despite this, according to the complaint, company insiders sold a large amount of stock without disclosing the results of the trial. This class Read more
Sacklers, Others Cost Pennsylvania Billions via Opioids Class Action
This class action brings suit against seventeen individuals, seven bearing the last or middle name “Sackler,” each of whom, the complaint alleges, has played a part in spreading opioid addiction in Pennsylvania. The complaint charges that they “have gained extreme monetary wealth and caused extreme financial harm to the addicted and their families.” Read more
Belviq Weight Loss Drugs Withdrawn Without Compensation Class Action
On its first presentation to the Food and Drug Administration (FDA) for approval, the weight-loss drug Belviq was rejected. After some additional studies, it was accepted by the FDA in 2012. This class action brings suit against Eisai, Inc. and Arena Pharmaceuticals over Belviq and Belviq XR, alleging that the companies knew the drugs increase Read more
Chantix Anti-Smoking Drug Contaminated with Nitrosamine Class Action
Pfizer, Inc. makes Chantix, an anti-smoking drug that contains an ingredient known as varenicline. However, the complaint for this class action alleges that the drug also contains “dangerously high levels of N-nitroso-varenicline, a carcinogenic impurity.” Although the drug has been recalled, the complaint alleges, Pfizer should have known about the impurity earlier, because of earlier Read more
Viatris and Mylan Epinephine Antitrust and RICO Violations Virginia Class Action
The complaint for this class action opens with the words, “This case presents one of the most egregious examples of corporate greed and malfeasance in our nation’s history.” It alleges that the companies behind EpiPens have violated antitrust laws and the Racketeer Influenced and Corrupt Organizations (RICO) Act to maintain a monopoly on the epinephrine Read more
Viatris, Mylan EpiPen Market Antitrust and RICO Violations Class Action
The sharp rise in the cost of EpiPens has been in the news as an example of the astronomical inflation of the cost of drugs. This case brings antitrust claims against Viatris, Inc. (the successor-in-interest to Mylan, NV), Mylan Specialty, LP, Mylan Pharmaceuticals, Inc. and Heather Bresch, alleging that “millions of American relying on this Read more
Pfizer’s Stop-Smoking Drugs Recalled for Contamination Class Action
Pfizer, Inc. makes Chantix, its brand-name drug that contains varenicline and helps people to stop smoking. The market for this varenicline-containing drug (VCD) is robust, but the complaint alleges that the VCDs in Chantix are “adulterated, misbranded, and unapproved” because they have been contaminated with the probable human carcinogen n-nitroso-varenicline and possibly with other potential Read more
